5% Amino acids solution
Composition
| 1000 ml infusion solution contains: | |||
|---|---|---|---|
| L-Isoleucine | 2.511 g | ||
| L-Leucine | 2.790 g | ||
| L-Lysine | 2.092 g | ||
| L-Methionine | 0.976 g | ||
| L-Phenylalanine | 1.813 g | ||
| L-Threonine | 1.743 g | ||
| L-Tryptophan | 0.558 g | ||
| L-Valine | 2.092 g | ||
| L-Arginine | 3.487 g | ||
| L-Histidine | 0.698 g | ||
| L-Alanine | 9.254 g | ||
| L-Aspartic acid | 4.045 g | ||
| N-Acetyl-L-cysteine | 0.160 g | ||
| L-Glutamic acid | 9.500 g | ||
| Glycine | 3.845 g | ||
| L-Proline | 4.185 g | ||
| N-Acetyl-L-tyrosine | 0.344 g | ||
| Nicotinamide | 0.060 g | ||
| Pyridoxine hydrochloride | 0.040 g | ||
| Riboflavin-5'-phosphate sodium salt | 0.0025 g | ||
| Potassium hydroxide | 1.403 g | ||
| Sodium hydroxide | 1.200g | ||
| Calcium chloride | 0.735 g | ||
| Magnesium acetate | 0.536 g | ||
| In water for injection | |||
| Yielding: | mEq/l | mmol/l | mg/l |
| Na + | 30 | 30 | 690 |
| K + | 25 | 25 | 978 |
| Ca ++ | 10 | 5 | 200 |
| Mg ++ | 5 | 2.5 | 61 |
| Acetate - | 5 | 5 | 295 |
| Cl - | 10 | 10 | 361 |
Description
Requirement adapted, carbohydrate-free 5% amino acid solution containing electrolytes and vitamins specially for prematures and infants.
1000 ml = 7.1 g N
True osmolarity: approx. 600 mOsm/l
Indications
Solution for the partial parenteral nutrition of prematures and infants. Supply of protein building blocks, electrolytes, vitamins and water in cases where oral food intake is either inadequate or impossible, in cases with increased protein requirements, protein deficiency or protein catabolism.
Dosage Intructions
For intravenous infusion. Use of a Babydos® infusion transfusion set with a mini-drop system (60 drops = 1 g ± 0.1 g) or an infusion controller (IDG pfrimmer) is recommended.
Dosage unless otherwise prescribed: in neonates, standard dosage 2.5 g amino acids (corresponding to 50 ml) per kg body weight per day. Infusion rate: 2-5 ml/kg BW/h or 2-5 drops/kg BW/min if a mini-drop system is used.
Adverse Reactions and Side Effects
Too rapid an infusion of amino acid solutions leads to renal losses and, in susceptible patients, nausea, flusing etc.
Reactions which may occur because of the solution or the technique of administration include fibrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extra vasation and hyper volemia. If an adverse reaction occurs, discontinue infusion. Initiate appropriate treatment and retain the remainder of the fluid for examination if deemed necessary.
Contraindications
This product is contraindicated in patients with disturbed amino acid metabolism, hyperkalaemia, advanced hepatic insufficiency, renal insufficiency due to kidney defects, hyperhydration conditions.
Presentation and Pack Sizes
Infusion solution in bottles containing 250 ml. Clinic packs available with 10 bottles.
Special Notes
Use with care in the presence of decompensated cardiac insufficiency: shock, disturbances of the acid base balance, prerenally induced oliguria or anuria should be treated before commencing parenteral nutrition. Ensure adequate renal function.
This product is suitable for total parenteral nutrition if used in combination with calorie solutions which should be supplied simultaneously in adequate dosages.
If intended for long-term administration, vitamins should be substituted separately.
Use only clear solution in condition of intact container.
Protect from light. Store below 25°C.
Bottle 250 ml Reg. No. DKL0411637049A1
HARUS DENGAN RESEP DOKTER.
Manufactured by:
PT Finusolprima Farma Internasional,
Bekasi -Indonesia
For:
PT KALBE FARMA Tbk.,
Bekasi - Indonesia
Under license from:
Baxter Deutschland GMBH, Germany
0 Komentar
Penulisan markup di komentar